Social Capital Hedosophia Holdings Corp. Stock News

IPOF stock and sibling IPOD stock are both on the move after Chamath Palihapitiya fueled SPAC speculation on Twitter. Here's what to know.

IPOF stock is a worthy speculation here, given Chamath's overall track record. Just keep an eye on the potential troubles over at his Clover Health.

Is paying a 50% premium for IPOF stock worth it? After weighing the good and the bad, I think it's too close to call.

Almost more than 50% above the redemption price, IPOF stock is a simple bet that the SPAC bubble will stay inflated. The post Social Capital Hedosophia VI is Priced for a Trade, Not an Investment appe

Chamath Palihapitiya has a strong track record, and with Stripe rumors in the mix, IPOF stock looks like a gamble worth considering. The post IPOF Stock Has No Target Yet, But Chamath Palihapitiya Is

The potential gains in IPOF stock could prove once and for all that it's OK to invest in a shell company with no identified merger target. The post Go SPAC Crazy With Social Capital Hedosophia Holding

Here are the key things to look for when evaluating a premerger blank-check company.

Social Capital Hedosophia Holdings Corp VI is the sixth of 26 SPACs its sponsor plans to bring to market. Should you buy IPOF stock?

Hint: There's going to be a lot of new alternatives for investors.

This week, Joe Biden will be inaugurated as the 46th president of the United States. While there concerns about riskier assets, including stocks under $20, heading into Election Day, it's clear market

This company could fit nicely into the notable SPAC investor's style.

Could they be involved in the next high-profile merger?

Chamath Palihapitiya's latest SPAC target is a different kind of fintech.

These "blank check" companies are a better fit for Buffett's style than you might think.

There was a lot of SPAC merger news for investors to digest this week. For a quick refresher, dive in with InvestorPlace.